Unknown

Dataset Information

0

In vivo evidence for ?2 nicotinic acetylcholine receptor subunit upregulation in smokers as compared with nonsmokers with schizophrenia.


ABSTRACT: BACKGROUND:Schizophrenia is associated with very high rates of tobacco smoking. The latter may be related to an attempt to self-medicate symptoms and/or to alterations in function of high-affinity ?2-subunit-containing nicotinic acetylcholine receptors (?2*-nAChRs). METHODS:Smoking and nonsmoking subjects with schizophrenia (n=31) and age-, smoking-, and sex-matched comparison subjects (n=31) participated in one [123I]5-IA-85380 single photon emission computed tomography scan to quantify ?2*-nAChR availability. Psychiatric, cognitive, nicotine craving, and mood assessments were obtained during active smoking, as well as smoking abstinence. RESULTS:There were no differences in smoking characteristics between smokers with and without schizophrenia. Subjects with schizophrenia had lower ?2*-nAChR availability relative to comparison group, and nonsmokers had lower ?2*-nAChR availability relative to smokers. However, there was no smoking by diagnosis interaction. Relative to nonsmokers with schizophrenia, smokers with schizophrenia had higher ?2*-nAChR availability in limited brain regions. In smokers with schizophrenia, higher ?2*-nAChR availability was associated with lower negative symptoms of schizophrenia and better performance on tests of executive control. Chronic exposure to antipsychotic drugs was not associated with changes in ?2*-nAChR availability in schizophrenia. CONCLUSIONS:Although subjects with schizophrenia have lower ?2*-nAChR availability relative to comparison group, smokers with schizophrenia appear to upregulate in the cortical regions. Lower receptor availability in smokers with schizophrenia in the cortical regions is associated with a greater number of negative symptoms and worse performance on tests of executive function, suggesting smoking subjects with schizophrenia who upregulate to a lesser degree may be at risk for poorer outcomes.

SUBMITTER: Esterlis I 

PROVIDER: S-EPMC4019710 | biostudies-literature | 2014 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

In vivo evidence for β2 nicotinic acetylcholine receptor subunit upregulation in smokers as compared with nonsmokers with schizophrenia.

Esterlis Irina I   Ranganathan Mohini M   Bois Frederic F   Pittman Brian B   Picciotto Marina R MR   Shearer Lara L   Anticevic Alan A   Carlson Jon J   Niciu Mark J MJ   Cosgrove Kelly P KP   D'Souza D Cyril DC  

Biological psychiatry 20131113 6


<h4>Background</h4>Schizophrenia is associated with very high rates of tobacco smoking. The latter may be related to an attempt to self-medicate symptoms and/or to alterations in function of high-affinity β2-subunit-containing nicotinic acetylcholine receptors (β2*-nAChRs).<h4>Methods</h4>Smoking and nonsmoking subjects with schizophrenia (n=31) and age-, smoking-, and sex-matched comparison subjects (n=31) participated in one [123I]5-IA-85380 single photon emission computed tomography scan to q  ...[more]

Similar Datasets

| S-EPMC3881431 | biostudies-literature
| S-EPMC3758251 | biostudies-literature
2006-09-22 | GSE5320 | GEO
| S-EPMC2748327 | biostudies-literature
| S-EPMC8542753 | biostudies-literature
| S-EPMC3935145 | biostudies-literature
| S-EPMC3738000 | biostudies-literature
| S-EPMC6588605 | biostudies-literature
| S-EPMC4978979 | biostudies-literature
| S-EPMC4501776 | biostudies-literature